¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"particle concentration fluorescence immunoassay"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® concentration ÇÑ±Û ³óµµ, ÁýÁß
¼³¸í   
  1. ³óµµ. ¿ë¾×À̳ª ¿ë¸ÅÀÇ Áú·® ¶Ç´Â Ã¼Àû¿¡ ´ëÇÑ ¿ëÁúÀÇ Áú·® ¶Ç´Â Ã¼Àû. 2. ÁýÁß. °øÅëÀÇ Áß½ÉÀ¸·Î ¸ô¸®´Â ÇÑ Á¡¿¡ ÁýÇÕÇϴ °Í.
¿µ¹® pH, hydrogen ion concentration ÇÑ±Û ¼ö¼ÒÀ̿³óµµÁö¼ö
¼³¸í   
  Ç÷¾×À̳ª ¼Òº¯¿¡¼­ ½Ç½ÃÇϴ °Ë»çÇ׸ñ. pH°Ë»ç´Â ÀÎüÀǠü¾×ÀÇ »ê¼º, ¾ËÄ®¸®¼ºÀ» ¾Ë¾Æº¸´Â Áß¿äÇÑ °Ë»çÀÌ´Ù. ÀÎü´Â ¾à¾ËÄ®¸®¼º¿¡ ¼ÓÇϳª, À̺¸´Ù pHÀÇ Áõ°¡³ª °¨¼Ò°¡ ³ªÅ¸³¯ °æ¿ì, »ý¸í¿¡ À§ÇèÀÌ ¹ß»ýÇÑ´Ù. ÀÎü³»¿¡´Â ÀÌ·± »êµµÀÇ Áõ°¨À» ¸·±âÀ§ÇØ, À̸¥¹Ù ¿ÏÃæÁ¦µéÀÌ ¸¹ÀÌ Á¸ÀçÇϸç, Æ¯È÷ ÇãÆÄ¿Í ÄáÆÏÀÌ ¿ÏÃæÀÛ¿ëÀ» ¼öÇàÇϴ ÁÖ¿ä±â°üÀÌ´Ù.
  
  ÄáÆÏÀº »êµµ°¡ ³ôÀ» °æ¿ì, ¼Òº¯¿¡¼­ »êµµ¸¦ Áõ°¡½ÃÄÑ ¹èÃâÇÔÀ¸·Î½á Ç÷¾×³»ÀÇ ¾ËÄ®¸®¼º ³óµµ°¡ Áõ°¡Çϵµ·Ï ÇÑ´Ù. ¶ÇÇÑ ÇãÆÄ¿¡¼­µµ, Ç÷¾×³»¿¡ »êµµ°¡ Áõ°¡½Ã È£ÈíÀ» Áõ°¡ÇÔÀ¸·Î½á ¹ÛÀ¸·Î »êÀÇ ¹èÃâÀ» Áõ°¡½ÃŲ´Ù. ÀÌ·± ÇãÆÄ¿Í ÄáÆÏÀÇ ±ÕÇüÀº ¾ÆÁÖ ÀûÀýÈ÷ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ¾î´À ÇÑ ±â°üÀÇ ÀÌ»óÀÌ ¹ß»ýÇϸé, ÀÌ·± ±ÕÇüÀº ±ú¾îÁö±â ½±´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • fluorescence immunoassay
    Çü±¤¸é¿ªºÐ¼®(¹ý)
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • competitive immunoassay
    °æÀï¸é¿ªºÐ¼®(¹ý)
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • immunoassay
    ¸é¿ªºÐ¼®(¹ý)
  • nephelometric immunoassay
    ȥŹ¸é¿ªºÐ¼®(¹ý), ºñŹ¸é¿ªºÐ¼®(¹ý)
  • background fluorescence
    ¹è°æÇü±¤
  • fluorescence
    Çü±¤
  • fluorescence activated cell sorter
    Çü±¤Ç¥Áö¼¼Æ÷ºÐ·ù±â
  • fluorescence microscope
    Çü±¤Çö¹Ì°æ
  • fluorescence microscopy
    Çü±¤Çö¹Ì°æ°Ë»ç(¹ý)
  • fluorescence quenching
    Çü±¤¾àÈ­
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle
    ÀÔÀÚ
  • fluorescence
    Çü±¤
  • background fluorescence
    ¹è°æÇü±¤
  • concentration
    ³óµµ, ÁýÁß
  • blood concentration
    Ç÷Áß³óµµ
  • stress concentration
    ÀÀ·ÂÁýÁß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • fluorescence immunoassay
    Çü±¤¸é¿ªºÐ¼®(¹ý)
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • substrate-labeled fluorescence immunoassay
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªºÐ¼®(¹ý)
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • background fluorescence
    ¹è°æÇü±¤
  • competitive immunoassay
    °æÀï¸é¿ªºÐ¼®(¹ý)
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • fluorescence
    Çü±¤
  • fluorescence microscope
    Çü±¤Çö¹Ì°æ
  • fluorescence microscopy
    Çü±¤Çö¹Ì°æ°Ë»ç
  • fluorescence quenching
    Çü±¤¾àÈ­
  • fluorescence activated cell sorter
    Çü±¤Ç¥Áö¼¼Æ÷ºÐ¸®±â
  • immunoassay
    ¸é¿ªºÐ¼®(¹ý)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • PCFIA => particle concentration fluorescence immunoassay
    ÀÔÀÚ³óÃàÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • FETI => fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀÌ¸é¿ªÃøÁ¤(¹ý)
  • PETINIA => particle-enhanced turbidimetric inhibition immunoassay
    ÀÔÀÚÁõ´ëºñʾïÁ¦¸é¿ªÃøÁ¤(¹ý)
  • SLFIA => substrate-labeled fluorescence imunoassay
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • inhibition test, fluorescence
    Çü±¤¾ïÁ¦½ÃÇè, Çü±¤ÀúÁö½ÃÇè
  • EMMIA => enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªÃøÁ¤
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • homogeneous immunoassay
    ±ÕÁú¸é¿ªÃøÁ¤(¹ý)
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • immunoassay
    ¸é¿ªÇÐÀû ÃøÁ¤(¹ý)
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • prosthetic group-labeled immunoassay
    º¸Á¶±ºÇ¥Áö¸é¿ªÃøÁ¤(¹ý)
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle concentration fluorescence immunoassay
    ÀÔÀÚ³óÃàÇü±¤¸é¿ªÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • fluorescence correlation immunoassay
    Çü±¤»ó°ü¸é¿ªÃøÁ¤(¹ý)
  • fluorescence immunoassay
    Çü±¤¸é¿ªÃøÁ¤(¹ý)
  • fluorescence polarization immunoassay
    Çü±¤Æí±¤¸é¿ªÃøÁ¤(¹ý)
  • fluorescence protection immunoassay
    Çü±¤¹æ¾î¸é¿ªÃøÁ¤(¹ý)
  • substrate-labeled fluorescence immunoassay(sLFIA)
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • particle immunoassay
    ÀÔÀÚ¸é¿ªÃøÁ¤(¹ý)
  • particle-enhanced turbidimetric inhibition immunoassay
    ÀÔÀÚÁõ´ëºñʾïÁ¦¸é¿ªÃøÁ¤(¹ý)
  • background fluorescence
    ¹è°æÇü±¤
  • fluorescence
    Çü±¤
  • fluorescence activated cell sorter
    Çü±¤Ç¥Áö¼¼Æ÷ºÐ¸®±â FACS
  • fluorescence correlation
    Çü±¤»ó°ü
  • fluorescence excitation transfer
    Çü±¤¿©±âÀüÀÌ
  • fluorescence in situ hybridization
  • fluorescence microscope
    Çü±¤Çö¹Ì°æ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • concentration technique
    Áý¶õ¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • particle immunoassay
    ÀÔÀÚ ¸é¿ª(Ø£í­Øóæ¹)¾Æ½êÀÌ
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª(ý£áÈØóæ¹)¾Æ½êÀÌ
  • immunoassay
    ¸é¿ª(Øóæ¹)¾Æ½êÀÌ
  • depolarization fluorescence
    Å»ºÐ±Ø Çü±¤(÷­ÝÂпû«ÎÃ)
  • extrinsic fluorescence
    ¿ÜÀÎ Çü±¤ (èâì×û«ÎÃ)
  • fluorescence
    Çü±¤(û«ÎÃ)
  • fluorescence depolarization
    Çü±¤ Å»ºÐ±Ø(û«ÎÃ÷­ÝÂп)
  • fluorescence enhancement
    Çü±¤ Áõ°­(û«ÎÃñòË­)
  • fluorescence microphotolysis
    Çü±¤ ¹Ì¼¼±¤ºÐ¼®(û«ÎÃÚ°á¬ÎÃÝÂà°)
  • fluorescence microscope
    Çü±¤ Çö¹Ì°æ(û«ÎÃúéÚ°Ìð)
  • fluorescence microscopy
    Çü±¤ Çö¹Ì°æ¹ý(û«ÎÃúéÚ°ÌðÛö)
  • fluorescence polarization
    Çü±¤ Æí±¤(û«ÎÃø¶ÎÃ)
  • fluorescence quenching
    Çü±¤ ¼Ò±¤(û«ÎÃá¼ÎÃ)
  • intrinsic fluorescence
    °íÀ¯ Çü±¤(ͳêóû«ÎÃ)
  • active concentration
    Ȱ¼º³óµµ(üÀàõÒØÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fluorescence
    Çü±¤
  • immunoassay
    ¸é¿ªÇÐÀû°ËÁ¤¹ý
  • blood concentration
    Ç÷Áõ³óµµ
  • concentration
    ³óµµ, ³óÃà, ÁýÁß
  • permissible concentration
    Çã¿ë³óµµ
  • B-ray particle
    º£Å¸¼±ÀÔÀÚ
  • coarse particle
    Á¶¸³ÀÚ, °ÅÄ£ ÀÔÀÚ
  • diamagnetic particle
    ¹ÝÀÚ¼ºÀÔÀÚ
  • ferromagnetic particle
    öÀÚ¼ºÀÔÀÚ
  • heavy particle
    ÁßÀÔÀÚ
  • particle
    ÀÔÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCFIA particle concentration of fluorescence immunoassay
FIA fistula in ano; fluorescent immunoassay; focal immunoassay; Freund incomplete adjuvant
FPIA fluorescence polarization immunoassay
SPIF solid-phase immunoassay fluorescence
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCFIA Particle Concentration Fluorescence Immuno Assay
PACIA Particle Counting ImmunoAssay
FPIA Fluorescence Polarisation Immunoassay
FIA Fluorescence immunoassay
GCP Growth cone particle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fluorescence excitation transfer immunoassay
    Çü±¤ ¿©±â ÀüÀÌ ¸é¿ª ÃøÁ¤
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
    ¼Ò·®ÀÌ¶óµµ ±× Ȱ¼ºÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °í°¨µµÀÇ È¿¼Ò¸¦ Ç¥½ÃÀÚ·Î Çϰí Ç׿ø ȤÀº Ç×ü, ³ª¾Æ°¡¼­´Â ƯÀÌÀûÀ¸·Î ¹ÝÀÀÇÏ´Â ¹°Áú, lectin, C1q µîÀ» È­ÇÐÀûÀ¸·Î °áÇÕ½ÃÄÑ, Ç׿ø ȤÀº Ç×ü µûÀ§¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤, ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤¹ý
  • homogeneous immunoassay
    ±ÕÁú ¸é¿ª ÃøÁ¤, ±ÕÁú ¸é¿ª ÃøÁ¤¹ý
  • immunoassay test
    ¸é¿ª ºÐ¼®¹ý
    Ç׿ø¿¡ ´ëÇÑ Ç×ü°¡ °áÇÕÇÏ´Â ¹ÝÀÀÀº ±ØÈ÷ ƯÀÌÀûÀÎ °ÍÀ̰í Ç׿ø°ú Ç×ü°¡ ¹Ì·®ÀÌ¶óµµ ¹ÝÀÀÀº ÀϾ°í ¶Ç ±× °áÇÕ¹°Àº ¾ÈÁ¤ÇÏ´Ù. ÀÌ¿Í °°Àº Ç׿ø Ç×ü ¹ÝÀÀÀÇ Æ¯Â¡À» ÀÌ¿ëÇÔÀ¸·Î¼­ ¹Ì·®ÀÇ Ç׿øÀ̳ª Ç×ü¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • C-type virus particle
    CÇü ¹ÙÀÌ·¯½º ÀÔÀÚ
  • charged particle
    ÇÏÀü ÀÔÀÚ, ´ëÀü ÀÔÀÚ
  • charged particle radiation
    ÇÏÀü ÀÔÀÚ ¹æ»ç¼±, ´ëÀü ÀÔÀÚ ¹æ»ç¼±
  • coarse particle
    Á¶¸³ÀÚ, °ÅÄ£ ÀÔÀÚ
  • Dane particle
    µ¥ÀÎ ÀÔÀÚ
    1970³â Dane µî¿¡ ÀÇÇÏ¿© BÇü °£¿° ȯÀÚÀÇ Ç÷û ¼Ó¿¡¼­ ¹ß°ßµÈ Á÷°æ 42nmÀÇ ±¸»ó ÀÔÀÚ. ±×ÈÄ À̰ÍÀº BÇü °£¿° virusÀÇ ¿ÏÀü ÀÔÀÚ¶ó´Â °ÍÀÌ ¸í¹éÇÏ°Ô µÇ¾ú´Ù. ¿ÜÇǰ¡ ÀÖ°í ±× ³»ºÎÀÇ HBc Ç׿øÀº Á÷°æ 24nmÀÇ ±¸»óÀÇ ½ÉÀ¸·Î ÀÌ·ç¾îÁö°í, ½ÉÀÇ ³»ºÎ¿¡´Â ºÎºÐÀûÀ¸·Î 2Áß¼âÀÇ È¯»ó DNA°¡ ÀÖ´Ù. HBV °ü·Ã Ç׿øÀÎ HBsAg, HBcAg´Â °¢°¢ HBVÀÇ ¿ÜÇÇ, ½ÉÀÇ Ç׿øÀÌ´Ù.
  • dust like particle
    ¸ÕÁö °°Àº ÀÔÀÚ
  • filler particle
    ÃæÀüÁ¦ ÀÔÀÚ
  • heavy particle
    ÁßÀÔÀÚ
  • particle
    ÀÔÀÚ
    ¹°ÁúÀ» ±¸¼ºÇÏ´Â ÀÛÀº ÀÔÀÚ.
  • particle of tissue
    Á¶Á÷Æí
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
fluorescence immunoassay <technique> A sensitive technique which uses fluorescein, a fluorescent molecule, to measure the antigen or antibody concentration in a solution.
(09 Oct 1997)
fluorescence polarisation immunoassay A technique which takes advantage of the increased polarisation (non-random propagation of emission) of fluorescent light emissions when a fluorescent labelled antigen is bound by reagent antibody. The higher the concentration of unlabelled patient antigen present in the test mixture, the less bound fluorescent antigen is present and, consequently, the lower the polarisation of the fluorescent light emission. Standard calibration yields quantitative results.
(05 Mar 2000)
fluorescence polarization immunoassay Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labelled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.
(12 Dec 1998)
microparticle enzyme immunoassay A technique in which the solid-phase support consists of very small microparticles in liquid suspension. Specific reagent antibodies are covalently bound to the microparticles. Antigen, if present, is then "sandwiched" between bound antibodies and antigen-specific, enzyme-labelled antibodies. Antigen-antibody complexes are detected and quantitated by analysis of fluorescence from the enzyme-substrate interaction.
Acronym: MEIA
(05 Mar 2000)
solid phase immunoassay Immunoassay in which the antigen or serum is bound to a solid surface, such as a microplate wall or the sides of a tube, the other reactants being free in solution.
(05 Mar 2000)
double antibody immunoassay A method of separating antibody-bound antigen (e.g., insulin) from free antigen by precipitating the former with antibody specific for immunoglobulin.
Synonym: double antibody immunoassay, double antibody method.
(05 Mar 2000)
immunoassay <investigation> A process that measures and identifies a specific biological substance such as an antigen.
(09 Oct 1997)
thin-layer immunoassay A method for detection of antigen-antibody reactions, applicable to detection of either antigen or antibody, based on the fact that either reactant, when added to a polystyrene surface (such as a well in a polystyrene plate) is adsorbed as a thin layer and acts as an immunosorbent capable of binding with the second reactant.
(05 Mar 2000)
enzyme immunoassay The general term for an expanding technical arsenal of testing which allows a full range of quantitative analyses for both antigen and antibodies. These tests use colour-changed products of enzyme-substrate interaction (or inhibition) to measure the antigen-antibody reaction. Examples of EIA procedures (EMIT, ELISA, MAC, MEIA) follow.
Acronym: EIA
(05 Mar 2000)
enzyme-multiplied immunoassay technique A type of immunoassay in which the ligand is labelled with an enzyme, and the enzyme-ligand-antibody complex is enzymatically inactive, allowing quantitation of unlabelled ligand.
The test uses antibodies that react only with the particular drug for which the sample is being tested. The antibodies attach themselves to the drug if it is present in the sample. It is not designed to measure amounts of the drug present, only to detect its presence or absence.
It is used predominantly, but not exclusively, for the detection of drugs of abuse in the urine.
See: competitive binding assay, enzyme-linked immunosorbent assay.
(05 Mar 2000)
ratio imaging fluorescence microscopy <procedure> A method of measurement of intracellular pH or intracellular calcium levels, using a fluorescent probe molecule (see fura-2), in which the two different excitation wavelengths are used and the emitted light levels compared.
If emission at one wavelength is sensitive to the intracellular ion level and emission at the other wavelength is not, then standardisation for intracellular probe concentration, efficiency of light collection, inactivation of probe and thickness of cytoplasm can all be performed automatically.
(17 Dec 1997)
microscopy, fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilises antibodies that are labelled with fluorescent dye.
(12 Dec 1998)
spectrometry, fluorescence Measurement of the intensity and quality of fluorescence.
(12 Dec 1998)
Eranko's fluorescence stain <technique> Exposure of frozen sections to formaldehyde which produces a strong yellow-green fluorescence from cells containing norepinephrine.
(05 Mar 2000)
fluorescence <chemistry, physics> The emission of one or more photons by a molecule or atom activated by the absorption of a quantum of electro magnetic radiation.
Typically the emission, that is of longer wavelength than the excitatory radiation, occurs within 10exp 8 seconds: phosphorescence is a phenomenon with a longer or much longer delay in re radiation. Note that rays, X-rays, UV, visible light and IR radiations may all stimulate fluorescence.
(25 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fluorescence
    Çü±¤¼º
  • concentration
    ÁýÁß; Àü³ä
  • concentration
    ÁýÁß;Áý°á;Àü½ÉÀü·Â;ÁýÁß·Â;Àü·Å;³óÃà;(¾×üÀÇ)³óµµ;¼±±¤;³óÈ­;ÁýÁß¿¬±¸;¼ýÀÚ¸ÂÃ߱⠳îÀÌ
  • concentration camp
    Á¤Ä¡¹ü(Æ÷·Î)¼ö¿ë¼Ò
  • particle
    ºÐÀÚ,ÀÔÀÚ,ÀÛÀºÁ¶°¢,±Ø¼Ò·®,Ƽ²ø
  • alpha particle
    ¾ËÆÄÀÔÀÚ
  • beta particle
    º£Å¸ÀÔÀÚ
  • charged particle beam
    ÇÏÀü ÀÔÀÚ¼±
  • fundamental particle
    =ELEMENTARY PARTICLE
  • nobiliary prefix(particle)
    ¼º°ú À̸§»óÀÌ¿¡ ºÙ¿©¼­ ±ÍÁ·ÀÓÀ» ³ªÅ¸³»´Â ¸»(ÇÁ¶û½ºÀÇ de µ¶ÀÏÀÇvonµî)
  • particle
    ¹ÌºÐÀÚ;¹Ì·®;ÁúÁ¡;ºÒº¯È­»ç;Á¢µÎ»ç
  • particle accelerator
    ÀÔÀÚ °¡¼Ó±â
  • particle beam
    ÀÔÀÚ¼±;ÀÔÀÚºö
  • particle board
    Åé¹ä;¾ÐÃàÆÇ
  • particle physics
    ¼Ò¸³ÀÚ ¹°¸®ÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á